Today: 29 June 2026
UiPath stock (PATH) dips after CEO sale filing — what investors watch next after S&P MidCap 400 debut
4 January 2026
1 min read

UiPath stock (PATH) dips after CEO sale filing — what investors watch next after S&P MidCap 400 debut

NEW YORK, Jan 3, 2026, 18:13 ET — Market closed

  • UiPath shares fell about 3% in the last session, ending the week at $15.88.
  • A regulatory filing showed CEO Daniel Dines sold 45,000 shares under a pre-arranged trading plan.
  • UiPath entered the S&P MidCap 400 on Friday, putting index-related flows and liquidity in focus.

UiPath shares fell about 3% on Friday and were last at $15.88, underperforming the broader market on the first trading day of 2026.

The move mattered because UiPath joined the S&P MidCap 400 before Friday’s open, a change that can trigger buying by funds that track the index. S&P Dow Jones Indices said UiPath replaced Synovus Financial in the benchmark.

After the close, a filing showed UiPath CEO and Chairman Daniel Dines sold 45,000 Class A shares at a weighted average price of $16.3846. The form said the sale was made under a Rule 10b5-1 plan, a pre-arranged trading program that can allow executives to sell shares on a set schedule.

U.S. stocks ended mixed on Friday, with the Dow and S&P 500 higher and the Nasdaq slightly lower, a backdrop that kept investors focused on rate-sensitive technology names. “Investors might be a little bit more conscious about some of the valuations that they’re paying for some of the AI plays,” Joe Mazzola, head of trading & derivatives strategist at Charles Schwab, told Reuters. Reuters

The Form 4 said Dines’ sales prices ranged from $16.18 to $16.59, and he remained a major shareholder after the transaction through direct and indirect holdings.

UiPath sells automation software often described as robotic process automation, or RPA — tools that mimic routine computer tasks such as moving data between systems and filling out forms.

The company last reported results in December and forecast fourth-quarter fiscal 2026 revenue of $462 million to $467 million. UiPath also projected annual recurring revenue (ARR) — a subscription sales metric — of $1.844 billion to $1.849 billion as of Jan. 31, 2026, and non-GAAP operating income of about $140 million, a profit measure that excludes certain costs such as some stock-based compensation.

UiPath has not posted an upcoming events schedule for investors, according to its investor relations calendar, leaving the next earnings date as a watch item for traders looking for the next formal update on guidance.

Before Monday’s session, investors will be gauging whether index-related demand offers follow-through support after the initial addition, and whether the insider-sale disclosure weighs on sentiment despite the 10b5-1 structure.

Technical traders will be watching whether the stock holds Friday’s intraday low near $15.50 and can reclaim the $16.40 area, close to Friday’s opening price.

Macro data is also looming. The U.S. Labor Department is scheduled to release the December employment report on Friday, Jan. 9, followed by the December consumer price index on Tuesday, Jan. 13 — reports that can move Treasury yields and, in turn, valuations for growth-oriented software stocks.

Khadija Saeed is a financial markets reporter at TS2.tech, specializing in stocks, technology and emerging industries. She studied economics and finance at the London School of Economics and previously worked in market research before moving into financial journalism. Her coverage focuses on the companies, innovations and economic trends influencing global investors.

Stock Market Today

  • Fluor's Russell Index Additions and Pharma Feasibility Studies Could Shift Investment Outlook
    June 29, 2026, 12:41 AM EDT. Fluor Corporation (NYSE: FLR) was added to multiple Russell growth indexes in June 2026, boosting its visibility in key equity benchmarks. Concurrently, it began feasibility studies for Voyageur Pharmaceuticals on an iodine project linked to Bayer and a new contrast media manufacturing facility in North America. These moves might broaden Fluor's market exposure beyond its traditional engineering and construction segments. While the developments support Fluor's backlog and diversification story, analysts caution the near-term focus remains on managing execution risks and cash flow volatility. Fluor projects $18.3 billion revenue and $443.4 million earnings by 2029, requiring steady growth amid potential cost and labor challenges. Investor opinions vary, with some seeing upside potential beyond current valuations, while others stress caution due to operational risks.

Latest articles

Trump-era loan caps could open door for private lenders in grad school market

Trump-era loan caps could open door for private lenders in grad school market

29 June 2026
July 1 federal loan caps slash Grad PLUS access, forcing many graduate and professional students to seek private loans; Sallie Mae projects up to 70% origination growth over several years, while SoFi reports record student-loan volume—investors now face a real-time test of how much demand shifts to private lenders as federal limits hit.
IREN Limited (NASDAQ:IREN) slides as Warriors badge faces AI revenue test

IREN Limited (NASDAQ:IREN) slides as Warriors badge faces AI revenue test

29 June 2026
IREN Limited (NASDAQ:IREN) plunged 21.3% to $47.21 over five straight down days despite announcing a record $50M+ annual Warriors jersey deal, as investors focused on the company’s not fully contracted $4.4B target ARR and high short interest at 19.74% of float, with Friday’s close near the lowest analyst target.
Apple stock slips into 2026 as year-end tech pullback bites; AAPL earnings next
Previous Story

Apple stock slips into 2026 as year-end tech pullback bites; AAPL earnings next

Hyperscale Data (GPUS) stock jumps 20% in premarket as insider buying keeps spotlight on the microcap
Next Story

Hyperscale Data (GPUS) stock jumps 20% in premarket as insider buying keeps spotlight on the microcap

Go toTop